1. Home
  2. AMPH vs ROIC Comparison

AMPH vs ROIC Comparison

Compare AMPH & ROIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMPH
  • ROIC
  • Stock Information
  • Founded
  • AMPH 1996
  • ROIC 2007
  • Country
  • AMPH United States
  • ROIC United States
  • Employees
  • AMPH N/A
  • ROIC N/A
  • Industry
  • AMPH Biotechnology: Pharmaceutical Preparations
  • ROIC Real Estate Investment Trusts
  • Sector
  • AMPH Health Care
  • ROIC Real Estate
  • Exchange
  • AMPH Nasdaq
  • ROIC Nasdaq
  • Market Cap
  • AMPH 2.5B
  • ROIC 2.2B
  • IPO Year
  • AMPH 2014
  • ROIC N/A
  • Fundamental
  • Price
  • AMPH $39.54
  • ROIC $17.31
  • Analyst Decision
  • AMPH Buy
  • ROIC Hold
  • Analyst Count
  • AMPH 4
  • ROIC 6
  • Target Price
  • AMPH $60.33
  • ROIC $15.75
  • AVG Volume (30 Days)
  • AMPH 607.1K
  • ROIC 1.2M
  • Earning Date
  • AMPH 11-06-2024
  • ROIC 02-12-2025
  • Dividend Yield
  • AMPH N/A
  • ROIC 3.47%
  • EPS Growth
  • AMPH 17.38
  • ROIC 57.91
  • EPS
  • AMPH 3.01
  • ROIC 0.46
  • Revenue
  • AMPH $723,549,000.00
  • ROIC $336,785,000.00
  • Revenue This Year
  • AMPH $16.86
  • ROIC N/A
  • Revenue Next Year
  • AMPH $10.07
  • ROIC $0.97
  • P/E Ratio
  • AMPH $13.01
  • ROIC $37.74
  • Revenue Growth
  • AMPH 20.33
  • ROIC 4.18
  • 52 Week Low
  • AMPH $36.56
  • ROIC $11.87
  • 52 Week High
  • AMPH $65.92
  • ROIC $17.52
  • Technical
  • Relative Strength Index (RSI)
  • AMPH 30.89
  • ROIC 54.61
  • Support Level
  • AMPH $38.78
  • ROIC $16.41
  • Resistance Level
  • AMPH $45.39
  • ROIC $17.48
  • Average True Range (ATR)
  • AMPH 1.36
  • ROIC 0.05
  • MACD
  • AMPH -0.34
  • ROIC -0.06
  • Stochastic Oscillator
  • AMPH 15.69
  • ROIC 16.00

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the company sells insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has two reportable segments finished pharmaceutical products and API products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

About ROIC Retail Opportunity Investments Corp. (MD)

Retail Opportunity Investments Corp is a self-managed real estate investment trust. The company specializes in the acquisition, ownership and management of necessity-based community and neighborhood shopping centers on the west coast of the United States, anchored by supermarkets and drugstores. The Company's primary business is the ownership, management, and redevelopment of retail real estate properties.

Share on Social Networks: